US2022331311A1PendingUtilityA1

Tablet comprising 7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butoxy]-1h-quinolin-2-one or a salt thereof

Assignee: OTSUKA PHARMA CO LTDPriority: Oct 14, 2011Filed: Mar 7, 2022Published: Oct 20, 2022
Est. expiryOct 14, 2031(~5.2 yrs left)· nominal 20-yr term from priority
Inventors:Yoshiharu Inoue
A61K 9/2059A61K 9/0056A61K 31/496A61P 43/00A61K 9/2018A61P 25/18A61K 9/2813A61K 9/2866A61K 9/2054A61K 9/205A61K 9/2013
81
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

This invention relates to a tablet containing, as an active ingredient, 7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butoxy]-1H-quinolin-2-one or a salt thereof, that has excellent disintegration ability, storage stability and photostability. The tablet of the present invention comprising an uncoated tablet containing 7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butoxy]-1H-quinolin-2-one or a salt thereof as an active ingredient, excipients such as lactose, corn starch, and microcrystalline cellulose; disintegrants such as low-substituted hydroxypropylcellulose, croscarmellose sodium, and sodium carboxymethyl starch; binders such as hydroxypropylcellulose; lubricants such as stearate; and further comprising a coating layer containing hypromellose; talc; titanium oxide; colorant; and the like, the coating layer being applied to the surface of the uncoated tablet.

Claims

exact text as granted — not AI-modified
1 - 12 . (canceled) 
     
     
         13 . A tablet comprising 7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butoxy]-1H-quinolin-2-one or a salt thereof as an active ingredient. 
     
     
         14 . The tablet according to  claim 13 , further comprising:
 an excipient (a), a binder (b), a disintegrant (c) and a lubricant (d),   wherein the excipient (a) is at least one member selected from the group consisting of sugars, sugar alcohols, starches, and celluloses;   the binder (b) is a cellulose derivative;   the disintegrant (c) is at least one member selected from the group consisting of cellulose derivatives and starch derivatives; and   the lubricant (d) is a stearate.   
     
     
         15 . The tablet according to  claim 14 ,
 wherein the excipient (a) is at least one member selected from the group consisting of lactose, corn starch, and microcrystalline cellulose;   the binder (b) is hydroxypropyl cellulose;   the disintegrant (c) is at least one member selected from the group consisting of low-substituted hydroxypropyl cellulose, croscarmellose sodium, and sodium carboxymethyl starch; and   the lubricant (d) is magnesium stearate.   
     
     
         16 . The tablet according to  claim 14 , wherein the tablet is an uncoated tablet comprising:
 0.05 to 25% by weight of 7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butoxy]-1H-quinolin-2-one or a salt thereof;   10 to 98.5% by weight of the excipient (a);   0.1 to 20% by weight of the binder (b);   1 to 25% by weight of the disintegrant (c); and   0.1 to 10% by weight of the lubricant (d), with respect to the weight of the uncoated tablet.   
     
     
         17 . The tablet according to  claim 14 , wherein per 1 part by weight of 7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butoxy]-1H-quinolin-2-one or a salt thereof, the tablet comprises:
 1 to 2000 parts by weight of the excipient (a);   0.01 to 100 parts by weight of the binder (b);   0.1 to 500 parts by weight of the disintegrant (c); and   0.01 to 50 parts by weight of the lubricant (d).   
     
     
         18 . The tablet according to  claim 13 , which further comprises a coating layer on the surface thereof. 
     
     
         19 . The tablet according to  claim 18 , which further comprises the colorant (e) in the coating layer,
 wherein the colorant (e) contains an iron oxide, and
 the tablet contains 0.1 to 50% by weight of the colorant (e) with respect to the weight of the coating layer. 
   
     
     
         20 . The tablet according to  claim 13 , which is obtained by forming, into a tablet, a granulated substance obtained through wet granulation. 
     
     
         21 . The tablet according to  claim 13 , wherein the tablet does not contain povidone or crospovidone. 
     
     
         22 . A method for producing a tablet, the method comprising the steps of:
 (1) granulating a mixture containing 7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butoxy]-1H-quinolin-2-one or a salt thereof, an excipient (a), a binder (b), and a disintegrant (c), and further mixing thereto a lubricant (d); and   (2) forming the obtained mixture into a tablet,
 wherein the excipient (a) is at least one member selected from the group consisting of sugars, sugar alcohols, starches, and celluloses; 
 the binder (b) is a cellulose derivative; 
 the disintegrant (c) is at least one member selected from the group consisting of cellulose derivatives and starch derivatives; and 
 the lubricant (d) is a stearate. 
   
     
     
         23 . The method for producing the tablet according to  claim 22 , further comprising the step of:
 (3) mixing a coating agent, a colorant (e), and a liquid medium to obtain a mixture, and coating the surface of the tablet using the mixture.

Join the waitlist — get patent alerts

Track US2022331311A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.